-
Germany’s Far Right, Edging Close to Power, Remains Close to Extremists
The Alternative for Germany party has tried to soften its hard-line image but is still privately working with extremists. It could win a state election on Sunday.
-
Russian Drone Strikes Office of Ukraine’s Intelligence Chief
The attack came as the American envoys Steve Witkoff and Jared Kushner were said to be planning imminent visits to Kyiv and to Moscow.
-
It’s Time to Grow Up: Joe Swanberg and Cory Michael Smith on “The Sun Never Sets”
Taking full advantage of its sun-kissed ambiance and featuring wonderfully lived-in performances from its central cast, director Joe Swanberg’s “The Sun Never Sets” is an understated, whimsical look at the ways adults fail to love one another, while also being a testament to how it’s never too late to start over, even if you think…
-
The World’s First Bugs Had Way More Legs
Meet the earliest known insects. Shaking hands with them will take a while.
-
Gloria Steinem Found Community and Clout Over the Dinner Table
Neither a home cook nor an enthusiastic eater, she used the dinner table as a place to forge relationships and foster change.
-
Wineries Are Offering Bingo, Picnics, Jewelry … and Sometimes Wine
With slumping sales and fewer tourists, California winemakers have turned to special events and classes to woo customers — even those who don’t drink.
-
The Best Way to Sear a Rib-Eye Steak for Labor Day
Starting off in a low-temperature oven and finishing on the grill yields a steak that’s not just good — it’s perfect.
-
Why the Hugging Face Hack Should Make You Worry More About A.I.
The attack by an aggressive “collective” of OpenAI agents shows the danger of artificial intelligence systems that organize themselves.
-
How OpenAI Limited the Probe of Its Bots’ Hack of Hugging Face
Researchers investigating how OpenAI’s A.I. agents were able to break into Hugging Face’s infrastructure weren’t allowed to look at the incident’s full scope.
-
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.